Skip to content

Author

Juan Armendáriz-Borunda

We have 3 of 21 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Adenoviral-Mediated SIRT1 Expression Restores Lung Architecture and Reduces Fibrotic Progression in Experimental Models.

Background: Pulmonary fibrosis (PF) involves remodeling of lung architecture and limited therapeutic options are available. Sirtuin 1 (SIRT1), an epigenetic regulator, has emerged as a promising antifibrotic target due to its role in apoptosis, inflammation, and chromatin remodeling. Methods: We evaluated the effects o...

Liliana Faridi Saavedra-Salazar, Nayabei Ruiz Ramirez, Hugo Christian Monroy-Rami Rez et al. · 0 citations
Open access Aug 2026

Pirfenidone restores metabolic hormones and cardiac autophagy via p-AMPK in MASH

Obesity promotes chronic inflammation and insulin resistance, disrupting key metabolic hormones (e.g., insulin and leptin) and triggering metabolic dysfunction-associated steatohepatitis (MASH). Obesity is commonly associated with cardiovascular disease. Autophagy preserves heart function in response to various stresse...

D. López-Cifuentes, A. Sandoval-Rodríguez, Rebeca Escutia-Gutiérrez et al. · 0 citations
Open access Jul 2026

Extrafollicular B cell peripheral subpopulations in Sjögren's disease: expansion of DN2 and aNAV B cells.

Evaluated the distribution of atypical memory B cells in patients with SjD and showed that aMBCs displayed heightened CD38 expression, signaling an activated phenotype primed for plasma cell differentiation, underscores the aNAV-DN2 axis as a central hallmark of B-cell dysregulation in SjD.

Victor Manuel Menchaca-Tapia, P. Ortiz-Lazareno, N. Espinoza-García et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.